Clinical Trial Update: Safety and Efficacy of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of Botulinum Toxin Type A for lower urinary tract symptoms due to benign prostatic hyperplasia has completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Lower Urinary Tract Symptoms

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Allergan | Conditions: Benign Prostatic Hyperplasia | Phase 2 | Status: COMPLETED | Results posted: 2014-04-04